Lacey, J., Hewitt, J., Daley-Morris, J. L., James, J., Stevens, J. and Blaizel, O. (2022) “Expert clinical framework report: Management of adverse events related to novel therapies for relapsed/refractory multiple myeloma (RRMM)”, Canadian Hematology Today. Toronto, Canada, 1(S11). doi: 10.58931/cht.2022.1S1130.